FRUZAQLA®
Effective treatment for patients with metastatic colorectal cancer.
Health related Quality of Life from FRESCO-2
Discover the health-related quality of life findings from FRESCO-21, highlighting how FRUZAQLA®2 supports stability and delays deterioration, as analyzed through patient-centered tools.
FRESCO-2: the pivotal FRUZAQLA® study
Learn more about FRESCO-2, the global, randomised, double-blind, multi-centric phase III pivotal FRUZAQLA®-study.
FRESCO-2: Plain Language Summary
Explore the FRESCO-2 lay summary, co-written with patients to simplify key findings and present groundbreaking research in an accessible way.
Materials for patients